Public Company News

Hanon Systems Supplies Highly Integrated Cooling Entity for Electric Vehicles

SEOUL, South Korea, March 31, 2026 /PRNewswire/ -- Hanon Systems (KS:018880), a leading global automotive thermal management supplier and subsidiary of Hankook & Company Group, today announced the company is supplying its innovative highly integrated cooling entity for electric vehicles.

2026-04-01 08:00 4129

Epsium Enterprise Limited Announces Board Changes

MACAU, March 31, 2026 /PRNewswire/ -- Epsium Enterprise Limited (Nasdaq: EPSM) ("Epsium" or the "Company") today announced a change in the composition of its Board of Directors (the "Board"), effective as of the dates described below. Mr. Kewei Joshua Cui has resigned from his positions as a memb...

2026-04-01 05:15 3810

Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland

* Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters * Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, expanding regional client support * Plans further investments to add capabilities and strengthe...

2026-03-31 22:00 4659

Xiao-I Corporation Provides Further Update on Shanghai Xiao-I's Patent Infringement Lawsuit Against Apple

SHANGHAI, March 31, 2026 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a leading developer of AI solutions, today provides an additional material update on its variable interest entity (VIE)'s ongoing patent infringement lawsuit against Apple Computer Trading (Shanghai) Co., Ltd., Apple Inc....

2026-03-31 21:25 6185

BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives

XI'AN, China, March 31, 2026 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading provider of bio-ingredient solutions in the natural, health, and personal care industries, announced today that on February 4, 2026 it entered into a Cooperation Framework Agree...

2026-03-31 21:00 4075

Co-PSMA data published in the European Urology journal

SYDNEY, March 31, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce that the results fro...

2026-03-31 20:58 3597

Tantech Receives NASDAQ Notification Regarding Minimum Bid Requirements

LISHUI, China, March 31, 2026 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") today announced that on March 26, 2026, it received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is currently not in compliance with the minimum bi...

2026-03-31 20:30 5468

Daesang Group Wins Two Gold Awards at the 2026 MUSE Creative Awards

- Wins Gold in Social Media and Event Categories at the IAA MUSE Creative Awards - Recognized for Social Media Strategy for Jongga and Ofood and Global Student Film Festival E.T.F.F. SEOUL, South Korea, March 31, 2026 /PRNewswire/ -- Daesang Group announced on the 31st that it has won two Gold Aw...

2026-03-31 20:00 3535

Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading

Public offering oversubscribed 1,073 times as medical imaging AI company debuts on HKEX HANGZHOU, China, March 31, 2026 /PRNewswire/ -- Hangzhou Diagens Biotechnology Co., Ltd. (HKEX: 02526) today began trading on the Main Board of The Stock Exchange of Hong Kong. Shares closed at HK$202.60, up ...

2026-03-31 18:34 5238

TOYO Co., Ltd Announces Second Half and Full Year 2025 Financial Results

TOKYO, March 31, 2026 /PRNewswire/ --  TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF),  ("TOYO" or the "Company"), a solar solution company,  today announced its financial results for the second half and fiscal year ended December 2025. FY 2025 Financial & Operational Hi...

2026-03-31 18:30 5988

Solar Industry Veteran Mr. Rhone Resch Joins TOYO as Chief Strategy Officer

TOKYO, March 31, 2026 /PRNewswire/ -- TOYO Co., Ltd (Nasdaq: TOYO) (OTC: TOYWF),  ("TOYO" or the "Company"), a global solar solution company,today announced the appointment of Rhone Resch as Chief Strategy Officer ("CSO"), a newly created role reporting directly to ...

2026-03-31 18:25 3642

iHuman Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results

BEIJING, March 31, 2026 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025.  Fourth Qu...

2026-03-31 18:06 5025

Ivonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026

HONG KONG, March 31, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK)  ("Akeso" or the "Company") announced the results of health-related quality of life (HRQoL) data (Poster: 107P) from the HARMONi-2 study at the 2026 European Lung Cancer Congress (ELCC). The study evaluated ivonescimab, the company's...

2026-03-31 17:40 3513

New Oriental to Report Third Quarter 2026 Financial Results on April 22, 2026

BEIJING, March 31, 2026 /PRNewswire/ -- New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced that it will report its financial results for the third quarter ended February 28...

2026-03-31 17:00 2765

Uxin Announces Official Opening of Its Tianjin Used Car Superstore

BEIJING, March 31, 2026 /PRNewswire/ -- Uxin Limited ("Uxin" or the "Company") ( Nasdaq: UXIN), China's leading used car retailer, today announced the official opening of its sixth used car superstore in the city of Tianjin. The Tianjin superstore integrates Uxin's in-house reconditioning factory ...

2026-03-31 14:30 2662

Abbisko Therapeutics' FGFR2/3 Inhibitor ABSK061 Receives FDA IND Clearance for Achondroplasia in Children

SHANGHAI, March 31, 2026 /PRNewswire/ -- On 30 March, 2026, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced thatthe U.S. Food and Drug Administration has cleared the Investigational New Drug (IND) application for ABSK061, a highly selective small-...

2026-03-31 14:10 3736

LEIFRAS Co., Ltd. Ranked No. 1 in Japan by Membership in Children's Sports Schools and by Number of Schools Where It Manages Club Activities

Advancing Sports Education in Japan Through the Development of Non-Cognitive Skills and Community-Based Club Activity Initiatives TOKYO, March 30, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and...

2026-03-31 09:00 3777

NAVER D2SF Makes Follow-On Investment in Soundable Health, an AI-Driven Health Tech Startup Scaling in the U.S. Market

SEOUL, South Korea, March 30, 2026 /PRNewswire/ -- NAVER D2SF, the corporate venture capital arm of NAVER, has made a follow-on investment in Soundable Health, a health tech startup leveraging AI-powered acoustic analysis to enable clinical-grade diagnostics through everyday devices. Having parti...

2026-03-31 08:30 4481

NAVER D2SF Makes Follow-On Investment in Nuvilab, AI Nutrition Analytics Startup

SEONGNAM, South Korea, March 30, 2026 /PRNewswire/ -- NAVER D2SF, the corporate venture capital arm of NAVER, has made a follow-on investment in Nuvilab, an AI-powered nutrition analytics healthcare startup. Following its seed investment shortly after the company's founding in 2021, NAVER D2SF ha...

2026-03-31 08:30 3907

Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema

* OLN324 demonstrated meaningfully faster and greater improvements in anatomic outcomes in DME and numerically greater vision gains sustained through 20 weeks with fewer retreatments as compared to faricimab * New anatomic data demonstrates OLN324 achieves faster, greater, and more durable re...

2026-03-31 08:00 4282
1 ... 15161718192021 ... 767